Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
151.3 USD | +0.89% | +5.36% | -20.90% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.90% | 18.96B | |
+28.79% | 42.68B | |
-3.12% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+7.16% | 24.94B | |
+28.94% | 12.3B | |
-2.28% | 11.95B | |
-1.63% | 11.55B | |
+17.67% | 11.32B |
- Stock Market
- Equities
- ALNY Stock
- News Alnylam Pharmaceuticals, Inc.
- Oppenheimer Adjusts Alnylam Pharmaceuticals' Price Target to $170 From $205, Maintains Outperform Rating